{"product_id":"vetmedin-ca-1-tablets-1-25mg","title":"Vetmedin CA-1 (Pimobendan) 1.25mg Chewable Tablets","description":"\u003cp align=\"center\"\u003e\u003cimg loading=\"lazy\" data-files=\"rx-map.jpg\" data-original=\"https:\/\/shopify-images-bucket.s3.us-west-2.amazonaws.com\/rx-map.jpg\" src=\"https:\/\/hordypaw.shop\/cdn\/shop\/files\/rx-map.webp\" class=\"img-responsive\" alt=\"RX MAP\" width=\"700\"\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eSupports Heart Health in Dogs With MMVD\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cstrong\u003eProduct Description\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eVETMEDIN®-CA1 Chewable Tablets are a veterinary-prescribed heart medication designed to delay the onset of \u003ca href=\"\/en-ro\/collections\/dog-medications\" title=\"Dog medications: allergy, antibiotics, heartworm \u0026amp; more! | hardypaw\" aria-label=\"Dog medications: allergy, antibiotics, heartworm \u0026amp; more! | hardypaw\"\u003econgestive heart failure in dogs\u003c\/a\u003e with Stage B2 preclinical myxomatous mitral valve disease. Formulated with pimobendan, it supports heart muscle function and blood flow through a dual action mechanism. The chewable, scored tablets allow accurate dosing and easier administration for long-term cardiac care.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eBenefits\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDelays Heart Failure: \u003c\/strong\u003eHelps extend the preclinical phase of Stage B2 MMVD by significantly delaying progression to congestive heart failure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDual Action Support: \u003c\/strong\u003eImproves cardiac contractility and promotes vasodilation by increasing calcium sensitivity and inhibiting phosphodiesterase III.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProven Clinical Use: \u003c\/strong\u003eSupported by multi-site clinical studies showing longer time to heart failure compared to placebo-treated dogs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEasy Administration: \u003c\/strong\u003ePalatable chewable tablets with score lines allow accurate dosing and improved compliance in dogs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eIngredients\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003eActive Ingredients\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cp\u003ePimobendan\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eHow to Use\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003eRecommended Dosage Chart\u003c\/strong\u003e\u003c\/h4\u003e\n\u003ctable style=\"width: 56.6071%;\" height=\"10\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 19.8556%;\" width=\"112\"\u003e\n\u003cp\u003e\u003cstrong\u003eDog Body Weight\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 27.7978%;\" width=\"157\"\u003e\n\u003cp\u003e\u003cstrong\u003eTotal Daily Labeled Dose\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 51.6245%;\" width=\"309\"\u003e\n\u003cp\u003e\u003cstrong\u003eDosing Frequency\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd style=\"width: 19.8556%;\" width=\"112\"\u003e\n\u003cp\u003ePer lb body weight\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 27.7978%;\" width=\"157\"\u003e\n\u003cp\u003e0.23 mg per lb\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd style=\"width: 51.6245%;\" width=\"309\"\u003e\n\u003cp\u003eDivided into two doses, approximately 12 hours apart\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch4\u003e\u003cstrong\u003eDosage \u0026amp; Administration Instructions\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrescription Only: \u003c\/strong\u003eThis product is labeled for use only by or on the order of a licensed veterinarian.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLabeled Daily Dose: \u003c\/strong\u003eThe total daily dose is labeled at 0.23 mg per lb body weight.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDivided Dosing: \u003c\/strong\u003eThe labeled daily amount is divided into two portions given approximately twelve hours apart.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eScored Tablets: \u003c\/strong\u003eChewable tablets are half-scored to allow dosing to the nearest half-tablet increment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVeterinary Oversight: \u003c\/strong\u003eUse is labeled only following veterinary diagnosis of Stage B2 preclinical MMVD.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cem\u003eDisclaimer: \u003c\/em\u003e\u003c\/strong\u003e\u003cem\u003eThis dosage information is provided by the manufacturer. Always consult your veterinarian before administering or adjusting any supplement for your pet.\u003c\/em\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAdditional Information\u003c\/strong\u003e\u003c\/h3\u003e\n\u003ch4\u003e\u003cstrong\u003ePrecautions\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRestricted Conditions: \u003c\/strong\u003eNot labeled for dogs with hypertrophic cardiomyopathy, aortic stenosis, or inappropriate cardiac output conditions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDisease Stage Use: \u003c\/strong\u003eLabeled only for dogs with Stage B2 preclinical MMVD and confirmed cardiomegaly.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDiagnostic Confirmation: \u003c\/strong\u003eDiagnosis should be supported by physical examination, radiography, and echocardiography findings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLimited Safety Data: \u003c\/strong\u003eSafety has not been established for dogs with non-MMVD heart disease or metabolic disorders.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003ePossible Side Effects\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRespiratory Signs: \u003c\/strong\u003eCough and increased breathing rate may occur and are commonly associated with MMVD progression.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive Upset: \u003c\/strong\u003eVomiting and diarrhea have been reported and were generally infrequent and self-limiting.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeurologic Events: \u003c\/strong\u003eCollapse, syncope, or seizures have been reported in some treated dogs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiac Changes: \u003c\/strong\u003eArrhythmias and lethargy may be observed and are often linked to disease progression.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003e\u003cstrong\u003eStorage Information\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoom Temperature: \u003c\/strong\u003eStore at controlled room temperature between 20°C and 25°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTemperature Excursions: \u003c\/strong\u003eShort-term storage between 15°C and 30°C is permitted.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSecure Storage: \u003c\/strong\u003eKeep tablets in a secure location away from pets to prevent accidental ingestion.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eShipping \u0026amp; Return\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eWe offer ground, express, priority, and international delivery; see our \u003ca aria-label=\"Shipping policy | hardypaw\" title=\"Shipping policy | hardypaw\" href=\"\/en-ro\/pages\/shipping-policy\"\u003eshipping policy\u003c\/a\u003e for details.\u003c\/p\u003e\n\u003cp\u003eFor return instructions or product concerns, please refer to our detailed \u003ca aria-label=\"Refund policy\" title=\"Refund policy\" href=\"\/en-ro\/policies\/refund-policy\"\u003erefund policy\u003c\/a\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePrescription items are NON-RETURNABLE and NON-REFUNDABLE. \u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eFrequently Asked Questions\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch3\u003e\u003cstrong\u003eQ1: What is VETMEDIN®-CA1 used for in dogs?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAns:\u003c\/strong\u003e VETMEDIN®-CA1 is labeled to delay the onset of congestive heart failure in dogs diagnosed with Stage B2 preclinical myxomatous mitral valve disease. It is intended for dogs showing cardiomegaly and a moderate or loud mitral heart murmur, but no clinical heart failure signs.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eQ2: How does pimobendan work in VETMEDIN®-CA1?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAns:\u003c\/strong\u003e Pimobendan works through a dual mechanism by increasing calcium sensitivity in heart muscle fibers and inhibiting phosphodiesterase III. This combination supports stronger heart contractions and improved blood vessel relaxation, helping maintain effective cardiac function in dogs with preclinical MMVD.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eQ3: Is VETMEDIN®-CA1 a prescription medication?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAns:\u003c\/strong\u003e VETMEDIN®-CA1 is a prescription-only veterinary medication. Federal law restricts its use to dogs under the supervision or order of a licensed veterinarian. It should only be used following proper diagnosis and veterinary evaluation of Stage B2 preclinical MMVD.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eQ4: Are there known side effects associated with VETMEDIN®-CA1?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAns:\u003c\/strong\u003e Reported side effects in dogs receiving VETMEDIN®-CA1 include cough, lethargy, vomiting, diarrhea, tachypnea, and arrhythmias. Many reported effects are consistent with disease progression rather than direct drug-related toxicity when used at labeled doses.\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eQ5: Can VETMEDIN®-CA1 be used for all stages of heart disease?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eAns:\u003c\/strong\u003e VETMEDIN®-CA1 is not labeled for use in dogs with Stage A or Stage B1 MMVD or in conditions such as hypertrophic cardiomyopathy or aortic stenosis. Its approved use is limited to dogs with confirmed Stage B2 preclinical MMVD.\u003c\/p\u003e","brand":"Boehringer Ingelheim","offers":[{"title":"50 tablets","offer_id":43391972016289,"sku":"168539","price":266.0,"currency_code":"RON","in_stock":true},{"title":"100 tablets","offer_id":44274762350753,"sku":"168539-PK2","price":527.0,"currency_code":"RON","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0593\/2446\/5313\/files\/vetmedin-ca-1-pimobendan-1-25mg-chewable-tablets-50-pet-medicine-249.jpg?v=1778531589","url":"https:\/\/hordypaw.shop\/en-ro\/products\/vetmedin-ca-1-tablets-1-25mg","provider":"HardyPaw","version":"1.0","type":"link"}